Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set

PURPOSE: To examine 12-month real-world visual acuity outcomes and treatment patterns in neovascular age-related macular degeneration (nAMD) eyes, including those with pigment epithelial detachment (PED), receiving ranibizumab or aflibercept. PATIENTS AND METHODS: Electronic medical records were use...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eye (Lond)
Hoofdauteurs: Lotery, A, Griner, R, Ferreira, A, Milnes, F, Dugel, P
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2017
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733295/
https://ncbi.nlm.nih.gov/pubmed/28731052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.143
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items